JP2014524464A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524464A5
JP2014524464A5 JP2014526594A JP2014526594A JP2014524464A5 JP 2014524464 A5 JP2014524464 A5 JP 2014524464A5 JP 2014526594 A JP2014526594 A JP 2014526594A JP 2014526594 A JP2014526594 A JP 2014526594A JP 2014524464 A5 JP2014524464 A5 JP 2014524464A5
Authority
JP
Japan
Prior art keywords
oxo
carboxamide
tetrahydroisoquinoline
pyrazol
isobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014526594A
Other languages
English (en)
Japanese (ja)
Other versions
JP6035334B2 (ja
JP2014524464A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/054305 external-priority patent/WO2013027196A1/en
Publication of JP2014524464A publication Critical patent/JP2014524464A/ja
Publication of JP2014524464A5 publication Critical patent/JP2014524464A5/ja
Application granted granted Critical
Publication of JP6035334B2 publication Critical patent/JP6035334B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014526594A 2011-08-25 2012-08-24 抗マラリア療法のための置換2−アルキル−1−オキソ−n−フェニル−3−ヘテロアリール−1,2,3,4−テトラヒドロイソキノリン−4−カルボキサミド Expired - Fee Related JP6035334B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161527594P 2011-08-25 2011-08-25
US61/527,594 2011-08-25
PCT/IB2012/054305 WO2013027196A1 (en) 2011-08-25 2012-08-24 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies

Publications (3)

Publication Number Publication Date
JP2014524464A JP2014524464A (ja) 2014-09-22
JP2014524464A5 true JP2014524464A5 (enExample) 2015-09-03
JP6035334B2 JP6035334B2 (ja) 2016-11-30

Family

ID=47018313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014526594A Expired - Fee Related JP6035334B2 (ja) 2011-08-25 2012-08-24 抗マラリア療法のための置換2−アルキル−1−オキソ−n−フェニル−3−ヘテロアリール−1,2,3,4−テトラヒドロイソキノリン−4−カルボキサミド

Country Status (19)

Country Link
US (1) US9416124B2 (enExample)
EP (1) EP2748147B1 (enExample)
JP (1) JP6035334B2 (enExample)
CN (1) CN103930404B (enExample)
BR (1) BR112014004437B1 (enExample)
CA (1) CA2846507C (enExample)
CY (1) CY1119748T1 (enExample)
DK (1) DK2748147T3 (enExample)
ES (1) ES2644082T3 (enExample)
HR (1) HRP20171567T1 (enExample)
HU (1) HUE034721T2 (enExample)
LT (1) LT2748147T (enExample)
ME (1) ME02908B (enExample)
PL (1) PL2748147T3 (enExample)
PT (1) PT2748147T (enExample)
RS (1) RS56544B1 (enExample)
SI (1) SI2748147T1 (enExample)
SM (1) SMT201700528T1 (enExample)
WO (1) WO2013027196A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019040499A2 (en) * 2017-08-21 2019-02-28 Navigen, Inc. ARF6 INHIBITORS AND ASSOCIATED METHODS
EP3892332A1 (en) * 2020-04-09 2021-10-13 University Of Kentucky Research Foundation New anti-malarial agents
BR112023021344A2 (pt) 2021-04-15 2023-12-19 Pags Co Ltd Derivados de isoquinolinas para uso como agentes antivirais e antitumorais
EP4074314A1 (en) 2021-04-15 2022-10-19 Valdospan GmbH Isoquinoline derivatives for use as antiviral and antitumour agents
WO2024083802A1 (en) 2022-10-17 2024-04-25 Valdospan Gmbh Isoquinoline derivatives as protein degraders, e7 degraders, antivirals, tumor therapeutics and immune suppressives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639761A (en) * 1994-02-14 1997-06-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
US5409938A (en) * 1994-02-14 1995-04-25 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
US6921762B2 (en) * 2001-11-16 2005-07-26 Amgen Inc. Substituted indolizine-like compounds and methods of use
WO2004004727A1 (en) * 2002-07-03 2004-01-15 Axys Pharmaceuticals, Inc. 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis
DE10237722A1 (de) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
DE10312963A1 (de) * 2003-03-24 2004-10-07 Aventis Pharma Deutschland Gmbh Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
MY145343A (en) * 2005-03-25 2012-01-31 Glaxo Group Ltd Novel compounds
RU2302417C1 (ru) * 2006-03-14 2007-07-10 Иващенко Андрей Александрович 1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека
CA2723612A1 (en) * 2008-05-19 2009-11-26 Actelion Pharmaceuticals Ltd Tetrahydroisoquinolines as antimalarial agents
GB0820856D0 (en) * 2008-11-14 2008-12-24 Univ Leuven Kath Novel inhibitors of flavivirus replication

Similar Documents

Publication Publication Date Title
AU2012382875B2 (en) Compound as WNT signaling inhibitor, composition, and use thereof
JP4216196B2 (ja) Npyアンタゴニストとしてのキノリン誘導体
JP2014508811A5 (enExample)
JP2014524464A5 (enExample)
JP2019031560A5 (enExample)
JP2009524670A5 (enExample)
JP2015529224A5 (enExample)
WO2012122340A1 (en) Soluble guanylate cyclase activators
JP2017525757A5 (enExample)
JP2016522835A5 (enExample)
JP2017533968A5 (enExample)
JP2013531074A5 (enExample)
JP2018531921A (ja) B型肝炎ウイルスコアタンパク質モジュレーター
JP2012532112A5 (enExample)
JP2005508313A5 (enExample)
JP2016513660A5 (enExample)
CN107108478B (zh) Urat1抑制剂
JP2016500661A5 (enExample)
JP2012507535A5 (enExample)
JP2011500550A5 (enExample)
JP2010536767A5 (enExample)
JP2015531774A5 (enExample)
JP2017528506A5 (enExample)
JP2016500063A5 (enExample)
JP2019531279A5 (enExample)